secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-113064
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 9.01, 2.03, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro completes $350M acquisition of Zoetis' medicated feed additive portfolio
-------------------------------------------------------------------------------

- Acquired >37 product lines across ~80 countries, six manufacturing sites in US, Italy, China, and >300 employees.
- Funded with $350M cash: $189M Delayed Draw Term A-1 Loans and $161M A-2 Loans under existing credit agreement.
- Expected to boost profitability, EBITDA margin, and be accretive to adjusted EPS; more details on Nov 7 Q1 call.
- Portfolio complements Phibro's vaccines, nutritional specialties, and mineral nutrition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924113064/0001104659-24-113064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000110465924113064/tm2427228d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-113064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer